The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Renal Toxicity of the Nonsteroidal Anti-Inflammatory Drugs
Abstract
NSAIDs pose little threat of renal insult in normal, healthy persons at therapeutic dosages. However, NSAID administration to susceptible persons may cause decrements in renal plasma flow and glomerular filtration rate within hours. Such acute noxious renal effects are mediated by products of arachidonic acid metabolism. Precipitous decrements in glomerular filtration and renal ischemia, manifested by increased serum creatinine and urea nitrogen, are possible. However, these effects are usually fully reversible with prompt discontinuation of the offending NSAID. Risk factors for the development of these acute renal effects are known. Acute interstitial nephritis with or without nephrotic syndrome is a rare form of renal toxicity that typically occurs between 2-18 months of use. Renal impairment may be so severe as to require temporary hemodialysis; however, renal function usually returns to normal upon discontinuation of the NSAID. The mechanism of acute interstitial nephritis is presumed to be of allergic origin but could also be caused by a reactive metabolite. Fenoprofen use appears to be associated with a much higher risk for its development. In contrast to the acute effects of NSAIDs, irreversible, analgesic-associated nephropathy manifested by papillary necrosis and chronic interstitial nephritis may occur following months to years of high doses of analgesic mixtures. The mechanism by which combination analgesics produce this form of renal injury is unknown and could be either a result of medullary ischemia or a direct effect of a reactive metabolite. An important issue to be resolved is the relationship between the acute, reversible, prostaglandin-mediated renal effects of the NSAIDs and chronic, irreversible destruction, if such a relationship exists. Theoretically, continual or repeated decrements in renal function in patients with predisposing risk factors could cause or contribute to progressive deterioration in renal function. Elevations in blood pressure or interference with the effects of antihypertensive medications could theoretically also contribute to long-term renal deterioration. In addition to renal syndromes caused by NSAIDs that result in renal impairment, other transient effects on electrolyte and water metabolism may also occur. Reduced secretion of sodium may result in formation of edema, exacerbation of heart failure, or increased blood pressure. Hyporeninemic-hypoaldosteronism may produce hyperkalemia. Finally, reduced excretion of water has rarely caused hyponatremia. It has been suggested that NSAIDs may be renoprotective in patients with nephrotic syndrome. Others have suggested that sulindac is "renal-sparing" because of a unique metabolic pathway that supposedly limits the exposure of the kidney to the active sulfide metabolite.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
The Progression of Renal Disease
Epstein, F. H., Klahr, S., Schreiner, G., & Ichikawa, I. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182505 · Cited by 828
Ciabattoni, G., Cinotti, G. A., Pierucci, A., Simonetti, B. M., Manzi, M., Pugliese, F., Barsotti, P., Pecci, G., Taggi, F., & Patrono, C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100502 · Cited by 329
Cytochrome P-450 Metabolism of Arachidonic Acid
McGiff, J. C. (1991) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.31.040191.002011 · Cited by 292
Analgesic Use and Chronic Renal Disease
Sandler, D. P., Smith, J. C., Weinberg, C. R., Buckalew, V. M., Dennis, V. W., Blythe, W. B., & Burgess, W. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905113201903 · Cited by 253
Reversible Renal Failure and Nephrotic Syndrome Associated with Nonsteroidal Anti-Inflammatory Drugs
Brezin, J. H., Katz, S. M., Schwartz, A. B., & Chinitz, J. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197912063012306 · Cited by 223
Metabolism of drugs by the kidney
Anders, M. W. (1980) · Kidney International · doi:10.1038/ki.1980.181 · Cited by 195
Utilization of nonsteroidal antiinflammatory drugs
Baum, C., Kennedy, D. L., & Forbes, M. B. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280613 · Cited by 186
Irreversible binding of zomepirac to plasma protein in vitro and in vivo.
Smith, P. C., McDonagh, A. F., & Benet, L. Z. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112392 · Cited by 159
Experimental renal papillary necrosis
MOLLAND, E. A. (1978) · Kidney International · doi:10.1038/ki.1978.2 · Cited by 126
Cited by
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Diclofenac residues as the cause of vulture population decline in Pakistan
Oaks, J. L., Gilbert, M., Virani, M. Z., Watson, R. T., Meteyer, C. U., Rideout, B. A., Shivaprasad, H. L., Ahmed, S., Iqbal Chaudhry, M. J., Arshad, M., et al. (2004) · Nature · doi:10.1038/nature02317 · Cited by 1,787
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
Tarr, P. I., Gordon, C. A., & Chandler, W. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71144-2 · Cited by 1,774
Cyclooxygenase-2: A Therapeutic Target
Turini, M. E., & DuBois, R. N. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103952 · Cited by 683
Metadata
- Authors
- Murray, M. D., & Brater, D. C.
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 1993-04
- Volume
- 33
- Issue
- 1
- Pages
- 435-465
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2167809710
- Cited by
- 294
- References
- 27
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal Toxicity of the Nonsteroidal Anti-Inflammatory Drugs. https://app.cochat.ai/papers/10.1146/annurev.pa.33.040193.002251
- The paper
- Murray, M. D., & Brater, D. C. (1993). Renal Toxicity of the Nonsteroidal Anti-Inflammatory Drugs. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev.pa.33.040193.002251
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.